Sotera Health Co (SHC)
11.02
+0.11
(+1.01%)
USD |
NASDAQ |
May 03, 16:00
11.02
0.00 (0.00%)
After-Hours: 20:00
Sotera Health Gross Profit Margin (Quarterly): 51.22% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 51.22% |
| December 31, 2023 | 58.05% |
| September 30, 2023 | 55.47% |
| June 30, 2023 | 54.68% |
| March 31, 2023 | 50.55% |
| December 31, 2022 | 56.33% |
| September 30, 2022 | 54.69% |
| June 30, 2022 | 56.40% |
| March 31, 2022 | 54.43% |
| December 31, 2021 | 55.52% |
| Date | Value |
|---|---|
| September 30, 2021 | 55.53% |
| June 30, 2021 | 57.07% |
| March 31, 2021 | 54.38% |
| December 31, 2020 | 55.61% |
| September 30, 2020 | 53.75% |
| June 30, 2020 | 55.83% |
| March 31, 2020 | 51.28% |
| December 31, 2019 | 50.25% |
| September 30, 2019 | 51.32% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
50.25%
Minimum
Dec 2019
58.05%
Maximum
Dec 2023
54.33%
Average
54.69%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 42.89% |
| XWELL Inc | 11.86% |
| ProPhase Labs Inc | -87.34% |
| Applied DNA Sciences Inc | 25.93% |
| Veracyte Inc | 70.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.51% |
| Return on Assets | 1.75% |
| Return on Invested Capital | 2.08% |
| Profit Margin (Quarterly) | 2.55% |
| Operating Margin (Quarterly) | 21.43% |
| Return on Net Operating Assets | 2.03% |